FRA:M12 - Deutsche Boerse Ag - DE000A0STSQ8 - Common Stock - Currency: EUR
FRA:M12 (3/7/2025, 7:00:00 PM)
14.8
+0.15 (+1.02%)
The current stock price of M12.DE is 14.8 EUR. In the past month the price increased by 5.71%. In the past year, price increased by 2.42%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
EMEIS.PA | EMEIS SA | 2.49 | 1.98B | ||
CLARI.PA | CLARIANE SE | N/A | 1.32B | ||
GDS.PA | RAMSAY GENERALE DE SANTE SA | N/A | 1.15B | ||
RHK.DE | RHOEN-KLINIKUM AG | 19.25 | 863.78M | ||
GHC.MI | GAROFALO HEALTH CARE SPA | 13.08 | 448.29M | ||
LNA.PA | LNA SANTE | 11.32 | 283.81M | ||
MED.DE | MEDICLIN AG | N/A | 136.80M | ||
LIK.DE | LIMES SCHLOSSKLINIKEN AG | N/A | 83.52M | ||
EIF.DE | MEDNATION AG | 1.32 | 4.21M |
M1 Kliniken AG engages in the provision of medical services in the field of beauty sector. The company is headquartered in Berlin, Berlin and currently employs 174 full-time employees. The company went IPO on 2015-09-14. The firm operates a chain of medical centers for aesthetic and plastic treatments, such as wrinkle treatments, lip treatments, breast corrections, liposuction, tummy tucks, upper arm lift, upper thigh lift, face lift, upper eyelid lift and the correction of labia, among others. In addition, the Company provides consultation services with registered doctors and specialists. The company operates medical centers in Berlin, Essen, Dusseldorf, Cologne and Munich.
M1 KLINIKEN AG
Gruenauer Strasse 5
Berlin BERLIN DE
Employees: 219
Company Website: https://www.m1-kliniken.de/
Investor Relations: http://www.m1-kliniken.de/en/investor-relations/m1-stock.html
Phone: 4930347474414
The current stock price of M12.DE is 14.8 EUR. The price increased by 1.02% in the last trading session.
The exchange symbol of M1 KLINIKEN AG is M12 and it is listed on the Deutsche Boerse Ag exchange.
M12.DE stock is listed on the Deutsche Boerse Ag exchange.
7 analysts have analysed M12.DE and the average price target is 28.05 EUR. This implies a price increase of 89.53% is expected in the next year compared to the current price of 14.8. Check the M1 KLINIKEN AG stock analysts ratings, price target forecast and up-and down grades for more detailed information.
M1 KLINIKEN AG (M12.DE) has a market capitalization of 290.67M EUR. This makes M12.DE a Micro Cap stock.
M1 KLINIKEN AG (M12.DE) currently has 219 employees.
M1 KLINIKEN AG (M12.DE) has a support level at 14.48 and a resistance level at 14.9. Check the full technical report for a detailed analysis of M12.DE support and resistance levels.
The Revenue of M1 KLINIKEN AG (M12.DE) is expected to grow by 12.09% in the next year. Check the estimates tab for more information on the M12.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
M1 KLINIKEN AG (M12.DE) has a dividend yield of 3.41%. The yearly dividend amount is currently 0. Check the full fundamental report for a detailed analysis of M12.DE dividend history, reliability and sustainability.
M1 KLINIKEN AG (M12.DE) will report earnings on 2025-04-29, after the market close.
The PE ratio for M1 KLINIKEN AG (M12.DE) is 17.41. This is based on the reported non-GAAP earnings per share of 0.85 and the current share price of 14.8 EUR. Check the full fundamental report for a full analysis of the valuation metrics for M12.DE.
ChartMill assigns a technical rating of 1 / 10 to M12.DE. When comparing the yearly performance of all stocks, M12.DE is a bad performer in the overall market: 79.63% of all stocks are doing better.
ChartMill assigns a fundamental rating of 7 / 10 to M12.DE. M12.DE has an excellent financial health rating, but there are some minor concerns on its profitability.
Over the last trailing twelve months M12.DE reported a non-GAAP Earnings per Share(EPS) of 0.85. The EPS increased by 163.63% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 5.03% | ||
ROA | 8.27% | ||
ROE | 15.32% | ||
Debt/Equity | 0.07 |
ChartMill assigns a Buy % Consensus number of 86% to M12.DE. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 89.39% and a revenue growth 12.09% for M12.DE